Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

BJ Slotman; H van Tinteren; John Praag; J L Knegjens; S Y El Sharouni; M Hatton; A Keijser; C Faivre-Finn; S Senan

doi:10.1016/s0140-6736(14)61085-0

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

BJ Slotman
, H van Tinteren
, John Praag
, J L Knegjens
, S Y El Sharouni
, M Hatton
, A Keijser
, C Faivre-Finn
, S Senan

Radiotherapy

Research output: Contribution to journal › Article › Academic › peer-review

552 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	36-42
Number of pages	7
Journal	Lancet (UK)
Volume	385
Issue number	9962
DOIs	https://doi.org/10.1016/s0140-6736(14)61085-0
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-32-04

Access to Document

10.1016/s0140-6736(14)61085-0

Cite this

@article{98c7aa9afd2a4a96885874306131f9a2,

title = "Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial",

author = "BJ Slotman and \{van Tinteren\}, H and John Praag and Knegjens, \{J L\} and \{El Sharouni\}, \{S Y\} and M Hatton and A Keijser and C Faivre-Finn and S Senan",

year = "2015",

doi = "10.1016/s0140-6736(14)61085-0",

language = "Undefined/Unknown",

volume = "385",

pages = "36--42",

journal = "Lancet (UK)",

issn = "0140-6736",

publisher = "Elsevier",

number = "9962",

}

TY - JOUR

T1 - Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

AU - Slotman, BJ

AU - van Tinteren, H

AU - Praag, John

AU - Knegjens, J L

AU - El Sharouni, S Y

AU - Hatton, M

AU - Keijser, A

AU - Faivre-Finn, C

AU - Senan, S

PY - 2015

Y1 - 2015

U2 - 10.1016/s0140-6736(14)61085-0

DO - 10.1016/s0140-6736(14)61085-0

M3 - Article

SN - 0140-6736

VL - 385

SP - 36

EP - 42

JO - Lancet (UK)

JF - Lancet (UK)

IS - 9962

ER -